These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. High dose of octreotide as a prophylaxis of post-ERCP pancreatitis. Andriulli A Gastrointest Endosc; 2007 Aug; 66(2):421; author reply 421-2. PubMed ID: 17643730 [No Abstract] [Full Text] [Related]
25. Prevention of post-ERCP pancreatitis. Haber GB Gastrointest Endosc; 2000 Jan; 51(1):100-3. PubMed ID: 10625814 [No Abstract] [Full Text] [Related]
26. Efficacy Versus effectiveness of octreotide in the prophylaxis of post-ERCP pancreatitis. Andriulli A; Loperfido S Am J Gastroenterol; 2007 Jul; 102(7):1539. PubMed ID: 17593163 [No Abstract] [Full Text] [Related]
27. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967 [TBL] [Abstract][Full Text] [Related]
28. Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial. Bai Y; Ren X; Zhang XF; Lv NH; Guo XG; Wan XJ; Nie ZG; Han ST; Bie P; Tian DA; Ji M; Li ZS Endoscopy; 2015 May; 47(5):415-20. PubMed ID: 25590178 [TBL] [Abstract][Full Text] [Related]
29. Pharmacotherapy for the prevention of post-ERCP pancreatitis. Foster E; Leung J Am J Gastroenterol; 2007 Jan; 102(1):52-5. PubMed ID: 17266688 [TBL] [Abstract][Full Text] [Related]
30. [Can post-ERCP acute pancreatitis be predicted and prevented?]. Heyries L Gastroenterol Clin Biol; 2001 Jan; 25(1 Suppl):1S241-6. PubMed ID: 11223596 [No Abstract] [Full Text] [Related]
31. Prophylactic effect of somatostatin in preventing Post-ERCP pancreatitis: an updated meta-analysis. Qin X; Lei WS; Xing ZX; Shi F Saudi J Gastroenterol; 2015; 21(6):372-8. PubMed ID: 26655132 [TBL] [Abstract][Full Text] [Related]
32. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis. Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865 [TBL] [Abstract][Full Text] [Related]
33. Preventing post-ERCP pancreatitis: where are we? Testoni PA JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013 [TBL] [Abstract][Full Text] [Related]
34. Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography. Chan HH; Lai KH; Lin CK; Tsai WL; Lo GH; Hsu PI; Wei MC; Wang EM J Chin Med Assoc; 2008 Dec; 71(12):605-9. PubMed ID: 19114324 [TBL] [Abstract][Full Text] [Related]
35. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials. Rudin D; Kiss A; Wetz RV; Sottile VM J Gastroenterol Hepatol; 2007 Jul; 22(7):977-83. PubMed ID: 17559376 [TBL] [Abstract][Full Text] [Related]